Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Endocrine Diseases
Vol. 1, Issue 2, 2013
August 15, 2013 EDT
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
Ilhan Satman
,
Hayley Bennett
,
Candeger Yilmaz
,
Sazi Imamoglu
,
Goksun Ayvaz
,
Abdurrahman Comlekci
,
Demet Ozkaya
,
Toros Sahin
,
turkey
type 2 diabetes
nph insulin
insulin glargine
cost effectiveness
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9858
JHEOR
1.
Satman I, Bennett H, Yilmaz C, et al. Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey.
JHEOR
. 2013;1(2):108-122.
doi:10.36469/9858
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats